STAT5b is a marker of poor prognosis, rather than a therapeutic target in glioblastomas.
Int J Oncol
; 61(4)2022 Oct.
Article
in En
| MEDLINE
| ID: mdl-36069226
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Brain Neoplasms
/
Glioblastoma
Type of study:
Prognostic_studies
Limits:
Humans
Language:
En
Journal:
Int J Oncol
Journal subject:
NEOPLASIAS
Year:
2022
Document type:
Article
Affiliation country:
Netherlands
Country of publication:
Greece